Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
66.13B | 67.94B | 60.54B | 54.95B | 44.81B | 49.07B | Gross Profit |
20.68B | 21.35B | 17.60B | 15.68B | 12.32B | 14.19B | EBIT |
6.83B | 7.15B | 4.73B | 3.55B | 1.44B | 2.31B | EBITDA |
8.94B | 9.46B | 6.98B | 5.88B | 3.31B | 3.85B | Net Income Common Stockholders |
5.75B | 5.41B | 3.41B | 2.51B | 865.17M | 1.59B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.86B | 7.86B | 7.41B | 7.21B | 8.07B | 6.82B | Total Assets |
72.37B | 72.37B | 62.86B | 55.58B | 50.82B | 46.67B | Total Debt |
14.88B | 14.88B | 15.77B | 12.41B | 13.04B | 11.87B | Net Debt |
7.59B | 7.03B | 8.36B | 5.21B | 4.98B | 5.04B | Total Liabilities |
31.79B | 31.79B | 29.55B | 26.47B | 25.16B | 22.38B | Stockholders Equity |
39.77B | 39.77B | 32.51B | 28.34B | 24.92B | 23.55B |
Cash Flow | Free Cash Flow | ||||
318.13M | 3.65B | 310.31M | 575.51M | 839.38M | 2.41B | Operating Cash Flow |
878.85M | 6.24B | 2.22B | 2.81B | 2.33B | 3.78B | Investing Cash Flow |
-308.16M | -2.04B | -2.00B | -2.30B | -1.53B | -2.65B | Financing Cash Flow |
-540.05M | -3.42B | -261.17M | -1.55B | 545.95M | 190.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥19.42B | 9.79 | 3.49% | 6.94% | 13.27% | ||
79 Outperform | ¥34.23B | 9.66 | 3.38% | 5.98% | 11.08% | ||
78 Outperform | ¥12.92B | 9.03 | 4.98% | 9.08% | 53.84% | ||
78 Outperform | ¥36.88B | 6.11 | 2.27% | 2.37% | 11.78% | ||
78 Outperform | ¥36.77B | 13.65 | 2.74% | 5.47% | 15.88% | ||
76 Outperform | ¥14.38B | 13.32 | 3.80% | 0.16% | 5.68% | ||
62 Neutral | $11.72B | 10.43 | -7.10% | 2.91% | 7.41% | -7.94% |